Emergent BioSolutions Inc. (EBS) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 661.26M |
| Enterprise Value | 1.03B |
| P/E Ratio | -47.68 |
| PEG Ratio | 0.4 |
| Price/Sales Ratio | 0.62 |
| Price/Book Ratio | 0.8 |
| Enterprise/Revenue | 1.23 |
| Enterprise/EBITDA | 5.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.01 |
| Operating Margin | 0.11 |
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
| Revenue | 742.9M |
| Revenue/Share | 13.04 |
| Gross Profit | 350.6M |
| EBITDA | 240.4M |
| Net Income | 52.6M |
| Diluted EPS | 0.93 |
| Total Cash | 160.3M |
| Total Cash/Share | 3.09 |
| Total Debt | 573.6M |
| Total Debt/Equity | 1.1 |
| Current Ratio | 4.29 |
| Book Value Per Share | 10.08 |
| 52-Week Change | 18.67 |
| 52-Week High | 14.06 |
| 52-Week Low | 5.62 |
| Moving Average 50 Days | 8.38 |
| Moving Average 200 Days | 9.72 |
| Average Volume | 795,551 |
| Shares Outstanding | 51.6M |
| % Held by Institutions | 81.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |